' '
Deutsch | English    

Research Database PMU-SQQUID


chosen keywordhuman platelet lysate (HPL)

Batch Effects during Human Bone Marrow Stromal Cell Propagation Prevail Donor Variation and Culture Duration: Impact on Genotype, Phenotype and Function.
Brachtl, G; Poupardin, R; Hochmann, S; Raninger, A; J├╝rchott, K; Streitz, M; Schlickeiser, S; Oeller, M; Wolf, M; Schallmoser, K; Volk, HD; Geissler, S; Strunk, D;
Cells. 2022; 11(6):
Full papers/articles (Journal)
Synergy of Human Platelet-Derived Extracellular Vesicles with Secretome Proteins Promotes Regenerative Functions.
Gomes, FG; Andrade, AC; Wolf, M; Hochmann, S; Krisch, L; Maeding, N; Regl, C; Poupardin, R; Ebner-Peking, P; Huber, CG; Meisner-Kober, N; Schallmoser, K; Strunk, D;
Biomedicines. 2022; 10(2):
Full papers/articles (Journal)
Transcription Factors STAT3 and MYC Are Key Players of Human Platelet Lysate-Induced Cell Proliferation.
Oeller, M; Jaksch-Bogensperger, H; Templin, M; Gehwolf, R; Rohde, E; Schallmoser, K; Laner-Plamberger, S;
Int J Mol Sci. 2022; 23(24):
Full papers/articles (Journal)
Improving Human Induced Pluripotent Stem Cell-Derived Megakaryocyte Differentiation and Platelet Production.
Krisch, L; Brachtl, G; Hochmann, S; Andrade, AC; Oeller, M; Ebner-Peking, P; Schallmoser, K; Strunk, D;
Int J Mol Sci. 2021; 22(15):
Full papers/articles (Journal)
Human Platelet Lysate for Good Manufacturing Practice-Compliant Cell Production.
Oeller, M; Laner-Plamberger, S; Krisch, L; Rohde, E; Strunk, D; Schallmoser, K;
Int J Mol Sci. 2021; 22(10):
Production and Quality Requirements of Human Platelet Lysate: A Position Statement from the Working Party on Cellular Therapies of the International Society of Blood Transfusion.
Schallmoser, K; Henschler, R; Gabriel, C; Koh, MBC; Burnouf, T;
Trends Biotechnol. 2020; 38(1):13-23
Human platelet lysate current standards and future developments.
Henschler, R; Gabriel, C; Schallmoser, K; Burnouf, T; Koh, MBC;
Transfusion. 2019; 59(4): 1407-1413.
Full papers/articles (Journal)
Upregulation of mitotic bookmarking factors during enhanced proliferation of human stromal cells in human platelet lysate.
Laner-Plamberger, S; Oeller, M; Mrazek, C; Hartl, A; Sonderegger, A; Rohde, E; Strunk, D; Schallmoser, K;
J Transl Med. 2019; 17(1): 432
Full papers/articles (Journal)
Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells
Oeller, M; Laner-Plamberger, S; Hochmann, S; Ketterl, N; Feichtner, M; Brachtl, G; Hochreiter, A; Scharler, C; Bieler, L; Romanelli, P; Couillard-Despres, S; Russe, E; Schallmoser, K; Strunk, D
THERANOSTICS. 2018; 8(5): 1421-1434.
Full papers/articles (Journal)
Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.
Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Kashofer, K; Stadelmeyer, E; Drexler, C; Lanzer, G; Linkesch, W; Strunk, D;
Transfusion. 2007; 47(8):143-146
Full papers/articles (Journal)